Clinical Trial Update: Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

This update covers the results of a Phase 2 trial testing whether ambulatory oxygen affects walking performance in patients with pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Snippet

Sponsor: University of Siena | Conditions: Pulmonary Fibrosis | Phase 2 | Status: COMPLETED